IR (InfraredFinance) 24-hour volatility at 40.6%: Trading volume surge triggers sharp price fluctuations
Bitget Pulse2026/04/28 13:14Volatility Overview
In the past 24 hours, the IR price hit a low of $0.02507 and a high of $0.03524, with the current price at $0.03478, reflecting a swing of up to 40.6%. The 24-hour trading volume surged to approximately $4.47 million.
Brief Analysis of Market Movements
- Abnormal trading volume spike: 24-hour trading volume reached $4.47 million, showing signs of a 3.7x abnormal volume pump, directly driving a price rebound from the lows.
- Simultaneous short-term selling pressure and rebound: After observing a 7.7x abnormal selling volume and a quick pump, there were no large whale transactions on-chain, but increased trading activity intensified volatility.
No official announcements, listings, or airdrop-related news events occurred in the past 24 hours.
Market Perspectives and Outlook
The prevailing sentiment in the X community is neutral to slightly bullish. Traders are watching for technical breakouts, as a price move near the red zone could prompt an over 60% surge, targeting $0.056; AI analysis suggests waiting for confirmation of a rebound above $0.05508. Caution is needed for the risk of losing support at $0.0285. If trading volume continues to increase or rebound is confirmed, the price may test above $0.035.
Note: This analysis is auto-generated by AI based on public data and on-chain monitoring, for information purposes only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.
Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market
Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.
Crypto prices
More
